logo
ENTITY

China Resources Dubl Crne Phrmctl (600062 CH)

24
Analysis
Health Care • China
China Resources Double-Crane Pharmaceutical Co., Ltd. develops, manufactures and markets a variety of medical products. The Company's products include anti-influenza, antihypertensives, and antibiotics.
more
Exchange Announcement • 20 Dec 2024 08:00

Announcement on Progress of Clinical Drug Trial for Pregabalin Extended-Release Tablets by Wholly-owned Subsidiary China Resources Double-Crane Limin Pharmaceutical (Jinan) Co., Ltd.

Exchange Announcement • 18 Dec 2024 08:00

Announcement on Passing GMP Compliance Inspection

Exchange Announcement • 16 Dec 2024 08:00

Announcement on Implementation of Repurchasing and Canceling Registration of Restricted Stock Incentive Plan of 2021

Exchange Announcement • 12 Dec 2024 08:00

Announcement on Obtaining Drug Registration Certificate for Sodium Valproate Sustained-release Tablets (I) by Holding Subsidiary Hunan Xiangzhong Pharmaceutical Co., Ltd.

Exchange Announcement • 12 Dec 2024 08:00

Announcement on Independent Director Receiving Warning Letter from Beijing Office of China Securities Regulatory Commission

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x